Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: Implication in phorbol ester-induced tumour promotion

Cell Proliferation

Volumn 33, Issue 3, 2000, Pages 167-187

  Eto, Isao ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; CYCLIC AMP RESPONSIVE ELEMENT; DNA SEQUENCE; EPIDERMIS CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SEQUENCE HOMOLOGY; TUMOR PROMOTION;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CELLS, CULTURED; CLONING, MOLECULAR; CYCLIN D1; DNA PRIMERS; EPIDERMIS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RATS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; RODENTIA;

EID: 0033868085     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2000.00176.x     Document Type: Article

References (72)

1. AHMAD M, THEOFANIDIS P, MEDFORD RM (1998) Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J. Biol. Chem. 273, 4616.
2. AKESON R, BERNARDS R (1990) N-myc down regulates neural cell adhesion molecule expression in rat neuroblastoma. Mol. Cell. Biol. 10, 2012.
3. ALBANESE C, D'AMICO M, REUTENS AT et al. (1999) Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. J. Biol. Chem. 274, 34186.
4. ALBANESE C, JOHNSON J, WATANABE G, et al. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589.
5. AMARAVADI L, KING MW (1994) A rapid and efficient, nonradioactive method for screening recombinant DNA libraries. Biotechniques 16, 98.
6. AZIZKHAN JC, JENSEN DE, PIERCE AJ, WADE M (1993) Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3, 229.
7. BARNES DM, GILLETT CE (1998) Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 52, 1.
8. BEIER F, LEE RJ, TAYLOR AC, PESTELL RG, LUVALLE P (1999) Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes. Proc. Natl. Acad. Sci. USA 96, 1433.
9. BERNSTEIN LR, BEN-ARI ET, SIMEK SL, COLBURN NH (1991) Gene regulation and genetic susceptibility to neoplastic transformation: aP-1 and p80 expression in JB6 cells. Environ. Health Perspect. 93, 111.
10. BERNSTEIN LR, COLBURN NH (1989) AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244, 566.
11. BIANCHI AB, FISCHER SM, ROBLES AJ, RINCHIK EM, CONTI CJ (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 8, 1127.
12. CHERIYATH V, NOVINA CD, RO YAL (1998) TFII-I regulates Vbeta promoter activity through an initiator element. Mol. Cell. Biol. 18, 4444.
13. COLBURN NH, BRUEGGE WF, BATES et al. (1978) Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res. 38, 624.
14. COLBURN NH, FORMER BF, NELSON KA, YUSPA SH (1979) Tumour promoter induces anchorage independence irreversibly. Nature 281, 589.
15. COLBURN NH, KOEHLER BA, NELSON KJ (1980) A cell culture assay for tumor-promoter-dependent progression toward neoplastic phenotype: detection of tumor promoters and promotion inhibitors. Teratog. Carcinog. Mutagen. 1, 87.
16. COSPEDAL R, LOBO M, ZACHARY I (1999) Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. Biochem. J. 342, 407.
17. DONNELLAN R, CHETTY R (1998) Cyclin D1 and human neoplasia. Mol. Pathol. 51, 1.
18. DU H, ROY AL, ROEDER RG (1993) Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12,501.
19. ETO I (1998) Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose. Cell Prolif. 31, 71.
20. FRAME S, CROMBIE R, LIDDELL J et al. (1998) Epithelial carcinogenesis in the mouse: correlating the genetics and the biology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 353, 839.
21. FUKAMI-KOBAYASHI J, MITSUI Y (1998) The regulation of cyclin D1 expression in senescent human fibroblasts. Exp. Cell Res. 241, 435.
22. FUKUMOTO S, KOYAMA H, HOSOI M, et al. (1999) Distinct role of cAMP and cGMP in the cell cycle control of vascular smooth muscle cells: cGMP delays cell cycle transition through suppression of cyclin D1 and cyclin-dependent kinase 4 activation. Circ. Res. 85, 985.
23. GAGELIN C, TORU-DELBAUFFE D, GAVARET JM, PIERRE M (1999) Effects of cyclic AMP on components of the cell cycle machinery regulating DNA synthesis in cultured astrocytes. J. Neurochem. 73, 1799.
24. GARRAWAY IP, SEMPLE K, SMALE ST (1996) Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure. Proc. Natl. Acad. Sci. USA 93, 4336.
25. GRASSEL S, SICOT FX, GOTTA S, CHU ML (1999) Mouse fibulin-2 gene. Complete exon-intron organization and promoter characterization. Eur. J. Biochem. 263, 471.
26. GUTTRIDGE DC, ALBANESE C, REUTHER JY, PESTELL RG, BALDWIN AS Jr (1999) NF-kB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19, 5785.
27. HERBER B, TRUSS M, BEATO M, MULLER R (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9, 1295.
28. 1-to-S-phase transition. Mol. Cell. Biol. 19, 2690.
29. HIRSCH MR, GAUGLER L, DEAGOSTINI-BAZIN H, BALLY-CUIF L, GORIDIS C (1990) Identification of positive and negative regulatory elements governing cell-type-specific expression of the neural cell adhesion molecule gene. Mol. Cell. Biol. 10, 1959.
30. HOSOKAWA Y, ARNOLD A (1998) Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22, 66.
31. HUANG C, MA WY, YOUNG MR, COLBURN N, DONG Z (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA 95, 156.
32. JACOBSON AB, ZUKER M (1993) Structural analysis of energy dot plot of a large mRNA. J. Mol. Biol. 233, 261.
33. JAVAHERY R, KHACHI A, LO K, ZENZIE-GREGORY B, SMALE ST (1994) DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14, 116.
34. JOHANSSON E, SKOGMAN E, THELANDER L (1995) The TATA-less promoter of mouse ribonucleotide reductase R1 gene contains a TFII-I binding initiator element essential for cell cycle-regulated transcription. J. Biol. Chem. 270, 30162.
35. JOYCE D, BOUZAHZAH B, FU M, et al. RG (1999) Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kB-dependent pathway. J. Biol. Chem. 274, 25245.
36. KARIN M, LIU ZG, ZANDI E (1997) AP-1 function and regulation. Current Opinion Cell Biol. 9, 240.
37. KAUFMANN J, SMALE ST (1994) Direct recognition of initiator elements by a component of the transcription factor IID complex. Genes Dev. 8, 821.
38. KIM HG, MILLER DM (1998) A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells. Biochemistry 37, 2666.
39. KITAZAWA S, KITAZAWA R, MAEDA S (1999) Transcriptional regulation of rat cyclin D1 gene by CpG methylation status in promoter region. J. Biol. Chem. 274, 28787.
40. KRONEMANN N, NOCKHER WA, BUSSE R, SCHINI-KERTH VB (1999) Growth-inhibitory effect of cyclic GMP-and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression. Br. J. Pharmacol. 126, 349.
41. L'ALLEMAIN G, LAVOIE JN, RIVARD N, BALDIN V, POUYSSEGUR J (1997) Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14, 1981.
42. LALLEMAND F, COURILLEAU D, SABBAH M, REDEUILH G, MESTER J (1996) Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem. Biophys. Res. Commun. 229, 163.
43. LEE AB, COOPER TA (1995) Improved direct PCR screen for bacterial colonies: wooden toothpicks inhibit PCR amplification. Biotechniques 18, 225.
44. LI LH, NERLOV C, PRENDERGAST G, MACGREGOR D, ZIFF EB (1994) c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13, 4070.
45. LI JJ, WESTERGAARD C, GHOSH P, COLBURN NH (1997) Inhibitors of both nuclear factor-kB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 57, 3569.
46. MANZANO-WINKLER B, NOVINA CD, ROY AL (1996) TFII is required for transcription of the naturally TATA-less but initiator-containing Vb promoter. J. Biol. Chem. 271, 12076.
47. MARMILLOT P, SCOVELL W (1998) Enhancement of transcription factor, USF, binding to the adenovirus major late promoter: effect of dithiothreitol and high mobility group protein-1. Biochim. Biophys. Acta 1395, 228.
48. MULLER H, LUKAS J, SCHNEIDER A, et al. (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 91, 2945.
49. MUSA NL, RAMAKRISHNAN M, LI J, et al. (1999) Forskolin inhibits cyclin D1 expression in cultured airway smooth-muscle cells. Am. J. Respir. Cell. Mol. Biol. 20, 352.
50. PAL SK, ZINKEL SS, KIESSLING AA, COOPER GM (1991) c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site. Mol. Cell. Biol. 11, 5190.
51. PHILIPP A, SCHNEIDER A, VASRIK I, et al. (1994) Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14, 4032.
52. ROBLES A, CONTI CJ (1995) Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis (Lond.) 16, 781.
53. RODRIGUEZ-PUEBLA ML, ROBLES AI, CONTI CJ (1999) ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development. Mol. Carcinog. 24, 1.
54. ROY AL, CARRUTHERS C, GUTJAHR T, ROEDER RG (1993b) Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365, 359.
55. ROY AL, MALIK S, MEISTERERNST M, ROEDER RG (1993a) An alternative pathway for transcription initiation involving TFII-I. Nature 365, 355.
56. ROY AL, MEISTERERNST M, POGNONEC P, ROEDER RG (1991) Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354, 245.
57. SABBAH M, COURILLEAL D, MESTER J, REDEUILH G (1999) Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA 96, 11217.
58. SHERR CJ (1996) Cancer cell cycles. Science 274, 1672.
59. SHTIVELMAN E, BISHOP JM (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol. 11, 5446.
60. SIRICA AE (1996) Multistage carcinogenesis. In: Sirica AE, ed. Cellular and Molecular Pathogenesis. Philadelphia: Lippincott-Raven Publishers, 283.
61. SMALE ST, BALTIMORE D (1989) The 'initiator' as a transcription control element. Cell 57, 103.
62. SMITH R, PETERS G, DICKSON C (1995) Genomic organization of the mouse cyclin D1 gene (Cyl-1). Genomics 25, 85.
63. TRAN CP, FAMILARI M, PARKER LM, WHITEHEAD RH, GIRAUD AS (1998) Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells. Am. J. Physiol. 275, G85.
64. WATANABE G, ALBANESE C, LEE RJ, et al. (1998) Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Spl. Mol. Cell. Biol. 18, 3212.
65. WEINBERG RA (1996) The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines Mol. Ther. 2, 105.
66. WEINSTEIN IB, BEGEMANN M, ZHOU P et al. (1997) Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin. Cancer Res. 3, 2696.
67. WEIS L, REINBERG D (1992) Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes. FASEB J. 6, 3300.
68. WU Y, PATTERSON C (1999) The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I. J. Biol. Chem. 274, 3207.
69. YAN GZ, ZIFF EB (1997) Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci. 17, 6122.
70. ZHANG SY, LIU SC, GOODROW T, MORRIS R, KLEIN-SZANTO AJP (1997) Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol. Carcinog. 18, 142.
71. ZUKER M (1989) On finding all suboptimal foldings of an RNA molecule. Science 244, 48.
72. ZUKER M, JACOBSON AB (1995) 'Well-determined' regions in RNA secondary structure prediction: analysis of small subunit ribosomal RNA. Nucl Acids Res. 23, 2791.